IL22 and metabolic dysfunction-associated steatotic liver disease: In non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatohepatopathy (MASLD), IL-22 exerts protective effects by regulating lipid metabolism and suppressing inflammatory responses (34).